XROMI
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for XROMI, covering 2024-04-04 to 2026-04-28. Get the full timeline:
Most recent: EMA Authorised: Xromi (hydroxycarbamide) — Lipomed GmbH
6 regulatory and trial events tracked for XROMI, covering 2024-04-04 to 2026-04-28. Get the full timeline:
Most recent: EMA Authorised: Xromi (hydroxycarbamide) — Lipomed GmbH